World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 126 2863 2671 70 62 669 164768

Massimo F. Piepoli publications per year

The chart shows the history of publications by Massimo F. Piepoli between 1987 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Massimo F. Piepoli published across 40 years, from 1987 to 2026, averaging 20.5 papers a year. Output peaked at 74 publications in 2021. 41 of the 821 publications appeared in the last two years.

No. of publications
20 40 60
Bar chart. Horizontal axis: year, 1987 to 2026. Vertical axis: number of publications, 0 to 74. Peak 74 publications in 2021. 1987: 3 publications 1988: 1 publication 1989: 0 publications 1990: 3 publications 1991: 3 publications 1992: 2 publications 1993: 3 publications 1994: 9 publications 1995: 9 publications 1996: 3 publications 1997: 6 publications 1998: 9 publications 1999: 12 publications 2000: 16 publications 2001: 8 publications 2002: 14 publications 2003: 16 publications 2004: 17 publications 2005: 6 publications 2006: 21 publications 2007: 13 publications 2008: 12 publications 2009: 13 publications 2010: 18 publications 2011: 10 publications 2012: 9 publications 2013: 15 publications 2014: 17 publications 2015: 24 publications 2016: 28 publications 2017: 45 publications 2018: 53 publications 2019: 45 publications 2020: 73 publications 2021: 74 publications 2022: 63 publications 2023: 59 publications 2024: 48 publications 2025: 40 publications 2026: 1 publication
1987 2026

821 publications in total across all disciplines

View publications per year as a table
Massimo F. Piepoli: publications per year, 1987 to 2026
Year Publications
1987 3
1988 1
1989 0
1990 3
1991 3
1992 2
1993 3
1994 9
1995 9
1996 3
1997 6
1998 9
1999 12
2000 16
2001 8
2002 14
2003 16
2004 17
2005 6
2006 21
2007 13
2008 12
2009 13
2010 18
2011 10
2012 9
2013 15
2014 17
2015 24
2016 28
2017 45
2018 53
2019 45
2020 73
2021 74
2022 63
2023 59
2024 48
2025 40
2026 1
Total 821
Download as CSV

Massimo F. Piepoli publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Massimo F. Piepoli sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 661–680 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 669 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340 669
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Massimo F. Piepoli D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Massimo F. Piepoli sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 126–127 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 126 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252 126
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Massimo F. Piepoli is affiliated with the Sant'Anna School of Advanced Studies in Italy. The scientist's research primarily falls within the field of Medicine, with a strong focus on Cardiology and Cardiovascular Medicine. Their work encompasses various subfields including Complementary and Alternative Medicine, Surgery, Endocrinology, Diabetes and Metabolism, and Pulmonary and Respiratory Medicine.

The main topics in Massimo F. Piepoli's research include:

  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Cardiovascular and Exercise Physiology
  • Cardiac Health and Mental Health
  • Cardiac Pacing and Defibrillation Studies
  • Cardiovascular Effects of Exercise
  • Heart Rate Variability and Autonomic Control

The scientist has contributed to a notable number of publications across several frequent venues:

  • European Journal of Preventive Cardiology (130 publications)
  • European Journal of Heart Failure (60 publications)
  • European Heart Journal (25 publications)
  • Zenodo (CERN European Organization for Nuclear Research) (16 publications)
  • ESC Heart Failure (15 publications)

Massimo F. Piepoli has collaborated extensively with the following coauthors:

  • Marco Metra (87 joint publications)
  • Géza Hálasz (71 joint publications)
  • Andrew J.S. Coats (70 joint publications)
  • Piergiuseppe Agostoni (65 joint publications)
  • Ovidiu Chioncel (55 joint publications)

Selected recent papers include:

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2021, European Heart Journal)
  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice (2021, European Heart Journal)
  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2022, European Journal of Heart Failure)
  • 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2023, European Heart Journal)
  • 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease (2020, European Heart Journal)

Best Publications

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

    Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

    Theresa A McDonagh;Marco Metra;Marianna Adamo;Roy S Gardner

  • 2016 European Guidelines on cardiovascular disease prevention in clinical practice

    Massimo F. Piepoli;Arno W. Hoes;Stefan Agewall;Christian Albus

  • 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

    Gilles Montalescot;Udo Sechtem;Stephan Achenbach;Felicita Andreotti

  • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

    Kenneth Dickstein;Alain Cohen-Solal;Gerasimos Filippatos;John J V McMurray

  • 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy : The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)

    Michele Brignole;Angelo Auricchio;Gonzalo Baron-Esquivias;Pierre Bordachar

  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    Frank L J Visseren;François Mach;Yvo M Smulders;David Carballo

  • 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

    Stephan Windecker;Philippe Kolh;Fernando Alfonso;Jean-Philippe Collet

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

    Marco Valgimigli;Héctor Bueno;Robert A Byrne;Jean-Philippe Collet

  • 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

    Jose Luis Zamorano;Patrizio Lancellotti;Daniel Rodriguez Muñoz;Victor Aboyans

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

    Marco Valgimigli;Héctor Bueno;Robert A. Byrne;Jean-Philippe Collet

  • 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

    Jose Luis Zamorano;Patrizio Lancellotti;Daniel Rodriguez Munoz;Victor Aboyans

  • Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH).

    MF Piepoli;CH Davos;DP Francis;AJ Coats

  • 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease.

    Antonio Pelliccia;Sanjay Sharma;Sabiha Gati;Maria Bäck

  • 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

    Victor Aboyans;Jean-Baptiste Ricco

  • Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation

    Massimo Francesco Piepoli;Ugo Corrà;Werner Benzer;Birna Bjarnason-Wehrens

  • GUIDELINES FOR PRE-OPERATIVE CARDIAC RISK ASSESSMENT AND PERIOPERATIVE CARDIAC MANAGEMENT IN NON-CARDIAC SURGERY

    Don Poldermans;Jeroen J. Bax;Eric Boersma;Stefan De Hert

  • Guidelines on myocardial revascularization.

    Philippe Kolh;William Wijns;Nicolas Danchin;Carlo Di Mario

Frequent Co-Authors

Andrew J.S. Coats
Andrew J.S. Coats The Heart Research Institute
Piotr Ponikowski
Piotr Ponikowski Wrocław Medical University
Darrel P. Francis
Darrel P. Francis Imperial College London
Gerasimos Filippatos
Gerasimos Filippatos National and Kapodistrian University of Athens
Marco Metra
Marco Metra University of Brescia
Frank Ruschitzka
Frank Ruschitzka University of Zurich
Michele Emdin
Michele Emdin Sant'Anna School of Advanced Studies
Tiny Jaarsma
Tiny Jaarsma Linköping University
Héctor Bueno
Héctor Bueno Spanish National Centre for Cardiovascular Research
Marco Guazzi
Marco Guazzi University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in healthcare but want alternative pathways to medical school, there are several flexible online options to explore. Many students pursue roles such as medical billing and coding, nursing, administration, or advanced practice nursing to build rewarding healthcare careers.

Entry-level positions like medical billing and coding are popular due to their accessibility and strong job outlook. If finances are a concern, you might be interested to learn can you get financial aid for medical billing and coding so you can start your journey without major upfront costs.

Nursing is another in-demand pathway. Prospective nurses may appreciate options such as lpn school without teas test, making entry into nursing education more accessible for diverse learners.

For those interested in leadership, a degree in healthcare administration can open doors to high-impact, non-clinical roles in hospitals and health organizations.

Experienced RNs seeking specialization might consider rn to fnp bridge programs, which offer accelerated options to become Family Nurse Practitioners. These diverse blended and online programs provide flexibility for busy professionals advancing their careers.

Best Scientists Citing Massimo F. Piepoli

Trending Scientists

Recently Published Articles